Artemis Wealth Advisors’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,137
| Closed | -$1.42K | – | 141 |
|
|
2022
Q1 | $1.42K | Hold |
1,137
| – | – | ﹤0.01% | 57 |
|
|
2021
Q4 | $1.32K | Hold |
1,137
| – | – | ﹤0.01% | 70 |
|
|
2021
Q3 | $2.18K | Hold |
1,137
| – | – | ﹤0.01% | 75 |
|
|
2021
Q2 | $2.66K | Hold |
1,137
| – | – | ﹤0.01% | 71 |
|
|
2021
Q1 | $3.08K | Hold |
1,137
| – | – | ﹤0.01% | 72 |
|
|
2020
Q4 | $2.75K | Hold |
1,137
| – | – | ﹤0.01% | 58 |
|
|
2020
Q3 | $2.6K | Hold |
1,137
| – | – | ﹤0.01% | 76 |
|
|
2020
Q2 | $2.62K | Hold |
1,137
| – | – | ﹤0.01% | 52 |
|
|
2020
Q1 | $1.96K | Hold |
1,137
| – | – | ﹤0.01% | 58 |
|
|
2019
Q4 | $2.35K | Hold |
1,137
| – | – | ﹤0.01% | 117 |
|
|
2019
Q3 | $3.3K | Hold |
1,137
| – | – | ﹤0.01% | 26 |
|
|
2019
Q2 | $4.46K | Hold |
1,137
| – | – | ﹤0.01% | 26 |
|
|
2019
Q1 | $5.37K | Hold |
1,137
| – | – | ﹤0.01% | 26 |
|
|
2018
Q4 | $2.61K | Hold |
1,137
| – | – | ﹤0.01% | 39 |
|
|
2018
Q3 | $7.09K | Hold |
1,137
| – | – | ﹤0.01% | 26 |
|
|
2018
Q2 | $7.78K | Hold |
1,137
| – | – | 0.01% | 26 |
|
|
2018
Q1 | $9.55K | Hold |
1,137
| – | – | 0.01% | 27 |
|
|
2017
Q4 | $10.5K | Hold |
1,137
| – | – | 0.01% | 25 |
|
|
2017
Q3 | $13.3K | Hold |
1,137
| – | – | 0.01% | 23 |
|
|
2017
Q2 | $47.5K | Hold |
1,137
| – | – | 0.04% | 11 |
|
|
2017
Q1 | $55.4K | Hold |
1,137
| – | – | 0.05% | 10 |
|
|
2016
Q4 | $37K | Buy |
+1,137
| New | +$37K | 0.03% | 6 |
|